Action
EGFR
Approval Jurisdiction
1998 FDA 2000 EMA
Approved for clinical use
EGFR breast cancer
CAS
180288-69-1
Commercial Vendor
Genentech
Compound Image
Trastuzumab.png
Compound name
Trastuzumab
Reference
Reference 2
Approved Drug List
1